Cytoprotective Effects of Natural Honey Against Doxorubicin Toxicity in Mice

January 2014 in “ Advances in bioscience and biotechnology ”

Madgida A. Ganash, Muhammad I. Mujallid, Ali A. Al-Robai, Ayoub A. Bazzaz

Studysummary This study concluded that daily ingestion of natural honey may protect against liver toxicity induced by Doxorubicin in male Albino mice. Our plain-language summary of this paper — not a Tressless recommendation.

The study investigated the protective effects of natural honey against Doxorubicin-induced toxicity in mice, finding that honey exhibited significant cytoprotective properties. This was evidenced by improved histopathological outcomes and biochemical markers in the honey-treated group compared to the control group. The findings suggested that honey could be a beneficial natural adjunct to reduce the adverse effects of Doxorubicin in clinical settings.

View this study on scirp.org →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

A Medicinal and Edible Formula YH0618 Ameliorates the Toxicity Induced by Doxorubicin via Regulating the Expression of Bax/Bcl-2 and FOXO4

research A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4

17 citations , January 2019 in “Journal of cancer”

This study found that the medicinal formula YH0618 may reduce toxicity from the chemotherapy drug doxorubicin, improving side effects like hair loss and organ damage, while maintaining its anti-cancer effects.

research Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity

102 citations , October 2010 in “Molecular Pharmaceutics”

In this study, copper-doxorubicin liposomes with multidose therapy reduced systemic toxicity compared to ammonium sulfate-loaded doxorubicin liposomes, while combinatorial strategies further enhanced tumor regression and accumulation.

research Original synthetic monophenolic antioxidant with combined effect inhibits tumor growth in vivo

2 citations , January 2025 in “Сибирский научный медицинский журнал”

In this study using a mouse model, the authors reported that the synthetic antioxidant TS-13 effectively inhibited tumor growth comparably to doxorubicin and reduced chemotherapy side effects, such as weight loss, splenotoxicity, and alopecia, more effectively when combined with the cytostatic treatment.

research Effects of Mitoquinone on Doxorubicin-Induced Cytotoxicity in H9c2 Cardiac Myoblasts and 22Rv1 Prostate Cancer Cells

June 2026 in “Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)”

This study observed that a 24-hour pre-treatment with MitoQ significantly protected H9c2 myoblasts from doxorubicin-induced damage while enhancing doxorubicin's effectiveness in prostate cancer cells, outperforming dexrazoxane's effects without compromising the anti-cancer efficacy.

research Bioabsorbable nano-micelle hybridized hydrogel scaffold prevents postoperative melanoma recurrence

4 citations , March 2023 in “Journal of controlled release”

This study reports that a novel bioabsorbable nano-micelle hybridized hydrogel scaffold may reduce postoperative melanoma recurrence and mitigate the side effects of doxorubicin in mouse models.